Stay updated on Aducanumab for Early Alzheimer's: Clinical Trial

Sign up to get notified when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Aducanumab for Early Alzheimer's: Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now presents the ClinicalTrials.gov record for Biogen’s Phase 3 EMERGE aducanumab study for early Alzheimer’s disease. It includes the study’s terminated status, design and outcome measures, eligibility and locations, and study documents.
    Difference
    100%
    Check dated 2026-11-11T02:13:35.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:50:42.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A site-wide NIH transition notice appears above the 403 error page, and the displayed site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:51:52.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The footer now displays website revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-07T00:52:27.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden message and minimal navigation, removing access to the full study record details and related resources.
    Difference
    17%
    Check dated 2026-09-23T01:02:58.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page shows Revision: v3.7.0 replacing Revision: v3.6.6. This represents a system or UI update, not changes to the study text.
    Difference
    0.0%
    Check dated 2026-09-16T00:14:29.000Z thumbnail image

Stay in the know with updates to Aducanumab for Early Alzheimer's: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.